| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7d7cc7d832ee2424ca6388e9ad108546 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-665 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-665
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12 |
| filingDate |
1997-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1999-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_070b4a7ed703b237d879b924e44e3eb7 |
| publicationDate |
1999-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-5866346-A |
| titleOfInvention |
Methods of using dynorphins as ligands for XOR1 receptor |
| abstract |
Orphan receptor expressed in Xenopus oocytes. The coupling of the receptor to a G protein-activated K+ channel was used as a functional essay in oocytcs. Endogenous opioid peptides dynorphins were found to activate the K+ channel by stimulating the orphan receptor. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6172067-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9109041-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009203618-A1 |
| priorityDate |
1995-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |